| ID | 1507 | |
| PMID | 15603887 | |
| Year | 2005 | |
| Sequence | TIAWFRMGGNCAIP ITVMEYTECSYNKS | |
| Name | gD 96-123 (group 2) | |
| Length | 28 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | not mentioned | |
| Mechanism | T-cell epitope peptide identified from HSV1-gD | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
| Enhancer | PBS (pH 7.3). | |
| Properties of enhancer | Not mentioned | |
| Concentration | 25ul | |
| Incubation time | 21 days | |
| Tissue permeability (value with units) | Gave lower but significant responses (p <0.05) | |
| Tissue Sample | eye | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C=O)CO)CCCCN)CC (=O)N)Cc1ccc(cc1)O)CO)CS)CCC(=O)O)[C@H](O)C) Cc1ccc(cc1)O)CCC(=O)O)CCSC)C(C)C)[C@H](O)C) [C@H](CC)C)CCC)[C@H](CC)C)C)CS)CC(=O)N)CCSC)CCCNC (=N)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C) [C@H](O)C | |